国药一致：12月15日召开董事会会议

Group 1 - The core point of the article is that Guoyao Yizhi (SZ 000028) held a temporary board meeting on December 15, 2025, to discuss the proposal for the third temporary shareholders' meeting of 2025 [1] - For the first half of 2025, Guoyao Yizhi's revenue composition was as follows: 70.21% from pharmaceutical wholesale, 29.28% from pharmaceutical retail, and 0.51% from other products [1] - As of the report date, Guoyao Yizhi's market capitalization was 13.7 billion yuan [1] Group 2 - The article also highlights concerns regarding the financial practices of Jiangsu Wuzhong, where the Qian siblings are accused of financial misconduct leading to the company's impending delisting [1]